Nowadays, carbon-based nanostructure materials are regarded as promising carriers for drug delivery to improve the effective treatment of diseases. The formation of covalent and noncovalent molecular bonds can be used for surface modification of nano-carriers in order to manipulate their toxicity, water solubility, and cellular internalization. Graphene and its derivatives have shown important potential in drug delivery systems. Among different graphene derivatives, Graphene Oxide (GO) is the most extensively used derivative. GO sheets have possessed certain oxygen functional groups including carboxylic acid groups at the edges, epoxy and hydroxyl groups on the basal planes. The oxygen groups on the surface of GO sheets enhance their capabilities for functionalization with chemical and bioactive molecules. In this review, we highlight the recent researches about the effect of reactive sites on the surface of GO and its derivatives in drug delivery systems. Therefore, the application of GO and its derivatives have been discussed as a delivery system in cancer treatment, gene therapy, and combination therapy, followed by discussions on their related issues. Finally, the review will provide a future perspective to the applications of GO-based materials as part of drug delivery systems, and may open up new viewpoints to motivate broader interests across these interdisciplinary fields.
26 February 2020 in Polymers for Advanced Technologies
The design of novel materials to use simultaneously in an ocular system for driven therapeutics and wound healing is still challenging. Here, we produced nanocomposites of tungsten disulfide carriers with spherical cobalt ferrite nanoparticles (NPs) as core inside a cubic iron oxide NPs shell (WS2/s-CoFe2O4@c-Fe3O4). Transmission electron microscopy (TEM) confirmed that 10 nm s-CoFe2O4@c-Fe3O4 NPs were attached on the WS2 sheet surfaces. The cytotoxicity of the WS2 sheets and nanocomposites were evaluated on bovine cornea endothelial cells (BCECs) using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay for a duration of three days. The MTT assay results showed low toxicity of the WS2 sheets on BCECs by 67% cell viability at 100 μg/mL in 24 h, while the nanocomposites show 50% cell viability in the same conditions. The magnetic resonance imaging (MRI) of nanocomposites revealed the excellent T2-weighted imaging with an r2 contrast of 108 mM−1 S−1. The in vitro photothermal therapy based on WS2 sheets and WS2/s-CoFe2O4 @c-Fe3O4 nanocomposites using 808 nm laser showed that the maximum thermal energy dispatched in medium at different applied power densities (1200 mw, 1800, 2200, 2600 mW) was for 0.1 mg/mL of the sample solution. The migration assay of BCECs showed that the wound healing was approximately 20% slower for the cell exposed by nanocomposites compared with the control (no exposed BCECs). We believe that WS2/s-CoFe2O4@c-Fe3O4 nanocomposites have a synergic effect as photothermal therapy agents for eye diseases and could be a target in an ocular system using MRI.